News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
160 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (23964)
Month
January (2946)
February (2976)
March (2714)
April (2913)
May (3635)
June (2415)
July (2091)
August (2656)
September (1618)
Day
1 (86)
3 (15)
4 (50)
5 (135)
6 (195)
7 (196)
8 (198)
9 (1)
11 (66)
12 (179)
13 (160)
14 (111)
15 (154)
18 (92)
19 (96)
20 (122)
21 (99)
22 (68)
24 (15)
25 (85)
26 (160)
27 (80)
28 (176)
29 (117)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
Day
1
3
4
5
6
7
8
9
11
12
13
14
15
18
19
20
21
22
24
25
26
27
28
29
Layoffs
Appia, Former Kite Cell Therapy Collaborator, Shuts Down
Appia Bio’s shutdown continues an unfortunate trend this year that has seen biotech closures nearly every month.
August 26, 2025
·
2 min read
·
Tristan Manalac
Obesity
Lilly Plots Path to FDA After Second Phase III Readout for Orforglipron
While Truist Securities analysts said the results from the ATTAIN-2 trial leave “room for competition,” they also pointed to a manufacturing advantage that could unlock a “double-digit billion dollar opportunity” for Eli Lilly.
August 26, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Femasys Announces Pricing of $8.0 Million Underwritten Public Offering
August 26, 2025
·
6 min read
Press Releases
Omnicell Appoints Baird Radford as Executive Vice President and Chief Financial Officer
August 26, 2025
·
6 min read
Press Releases
Acadia Pharmaceuticals Appoints Konstantina Katcheves as Senior Vice President, Chief Business and Strategy Officer
August 26, 2025
·
2 min read
Press Releases
Insulet Elevates Eric Benjamin to Chief Operating Officer
August 26, 2025
·
3 min read
Press Releases
Vir Biotechnology to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
August 26, 2025
·
1 min read
Press Releases
Praxis Medicines to Present at 36th International Epilepsy Congress 2025 in Lisbon, Showcasing Latest RADIANT Study Data and Leading Precision Epilepsy Pipeline
August 26, 2025
·
8 min read
Press Releases
Genentech and Roche Break Ground on State-of-the-Art Manufacturing Facility in Holly Springs, North Carolina
August 26, 2025
·
4 min read
Press Releases
jCyte Announces Publication of Phase I/IIa Safety Study of Retinal Progenitor Cells in Retinitis Pigmentosa in Frontiers in Cellular Neuroscience
August 26, 2025
·
3 min read
Previous
5 of 16
Next